Analysts are more negative on CVS Health after recent result...

Analysts are more negative on CVS Health after recent results, downgrading their EPS numbers for next year. The company's revenue growth is expected to slow, with a forecast 3.3% annualised growth rate until 2024, well below the historical 9.9% p.a. growth. The wider industry is expected to grow faster than CVS Health.